Operating Lease, Right-of-Use Asset of Finch Therapeutics Group, Inc. from 29 Feb 2016 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Finch Therapeutics Group, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 29 Feb 2016 to 30 Jun 2024.
  • Finch Therapeutics Group, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2024 was $25,441,000, a 6.8% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Finch Therapeutics Group, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $25,441,000 -$1,867,000 -6.8% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $26,018,000 -$5,809,000 -18% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 $26,584,000 -$6,168,000 -19% 31 Dec 2023 10-Q 13 Aug 2024 2024 Q2
Q3 2023 $26,589,000 -$13,766,000 -34% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $27,308,000 -$13,881,000 -34% 30 Jun 2023 10-Q/A 11 Aug 2023 2023 Q2
Q1 2023 $31,827,000 +$27,016,000 +562% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $32,752,000 +$27,699,000 +548% 31 Dec 2022 10-K 25 Mar 2024 2023 FY
Q3 2022 $40,355,000 +$35,055,000 +661% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $41,189,000 +$35,689,000 +649% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $4,811,000 -$989,000 -17% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $5,053,000 +$5,053,000 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q3 2021 $5,300,000 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $5,500,000 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $5,800,000 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q4 2020 $0 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q1 2016 $5,800,000 29 Feb 2016 10-K 31 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.